Akums Drugs and Pharmaceuticals MD, chairman, board of directors and AGM

Mutual fund votes, meeting of 10 Jul 2026, 5 fund houses so far (houses' deadline to file 15 Oct 2026)

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

• To receive, consider and adopt (a) the audited standalone financial statements of the Company for the financial year ended on March 31, 2026 and the reports of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statements of the Company for the financial year ended on March 31, 2026 and the report of Auditors thereon.MoreLess

  5 for0 against
• To declare dividend on the equity shares of the Company for the financial year ended on March 31, 2026

  5 for0 against
• To re-appoint Mr. Sanjay Sinha (DIN: 03627342) who retires by rotation as Director and being eligible, offers himself for re-appointment

  5 for0 against
• To ratify the remuneration of Cost Auditors for the financial year 2026-27

  4 for0 against
• To approve the revision in remuneration of Mr. Sanjeev Jain, Managing Director and Promoter of the Company

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, Jio BlackRock Mutual Fund

  • Angel One Mutual FundGovernance & transparency concern: Combined position of Chairman and Managing Director; the Company’s remuneration practice appears highly skewed among the Promoter Directors.
  • Edelweiss Mutual FundCompliant with law. No concern on the merits of proposed Director. Governance & transparency concern: Combined position of Chairman and Managing Director; the Company’s remuneration practice appears highly skewed among the Promoter Directors
  • Jio BlackRock Mutual FundSanjeev Jain, 60, is the Promoter and Managing Director. He received remuneration of Rs. 86.2 mn in FY26. His revised remuneration is capped at Rs. 120.0 mn; however, the company has not disclosed a component-wise break-up of his remuneration. Therefore, it is unclear what proportion of his pay is variable and linked to the company’s performance. Further, the aggregate promoter remuneration, inclusive of Sandeep Jain’s proposed remuneration (covered in Resolution #6), totals Rs. 240.0 mn, representing approximately 6.2% of FY26 profits, which is high and not commensurate with the size and scale of the business relative to peers. Given these concerns regarding the structure and quantum of his remuneration, we do not support the resolution.

  2 for3 against
• To approve the revision in remuneration of Mr. Sandeep Jain, Managing Director and Promoter of the Company

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, Jio BlackRock Mutual Fund

  • Angel One Mutual FundGovernance & transparency concern: No adequate justification for remuneration practice of company appears highly skewed among the Promoter Directors.
  • Edelweiss Mutual FundCompliant with law. No concern on the merits of proposed Directors. Governance & transparency concern: No adequate justification for remuneration practice of company appears highly skewed among the Promoter Directors
  • Jio BlackRock Mutual FundSandeep Jain, 58, is the Promoter and Managing Director. He received remuneration of Rs. 86.2 mn in FY26. His revised remuneration is capped at Rs. 120.0 mn; however, the company has not disclosed a component-wise break-up of his remuneration. Therefore, it is unclear what proportion of his pay is variable and linked to the company’s performance. Further, the aggregate promoter remuneration, inclusive of Sanjeev Jain’s proposed remuneration (covered in Resolution #5), totals Rs. 240.0 mn, representing approximately 6.2% of FY26 profits, which is high and not commensurate with the size and scale of the business relative to peers. Given these concerns regarding the structure and quantum of his remuneration, we do not support the resolution.

  2 for3 against

Mutual fund votes, meeting of 18 Jul 2025, 17 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

• To receive, consider and adopt (a.) the audited standalone financial statement of the Company for the financial year ended on 31st March, 2025 and the report of the Board of Directors and Auditors thereon; and (b) the audited consolidated financial statement of the Company for the financial year ended on 31st March 2025 and the report of Auditors thereon.MoreLess

  17 for0 against
• To appoint Mr. Sanjeev Jain (DIN: 00323433) who retires by rotation as Director and being eligible offers himself for re-appointment.

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund

  • Angel One Mutual FundGovernance concern: Skewed remuneration practice towards promoter directors.
  • Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. No concern on the merits of proposed Director. Governance concern: Skewed remuneration practice towards promoter directors.

  12 for5 against
• Appointment of Secretarial Auditors for five financial years from FY 2025-26 to FY 2029-30.

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund

  • Angel One Mutual FundProposed fee payable to Secretarial Auditors not disclosed.
  • Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundNo concern on merit of the proposed Secretarial Auditors. Non-Compliant with Regulation 36(5) of SEBI LODR: Proposed fee payable to Secretarial Auditors not disclosed.
  • Kotak Mahindra Mutual FundSPG & Associates will replace A.K. Nandwani & Associates as the secretarial auditors. Suresh Pandey, Partner at SPG & Associates, is appointed as the scrutinizer for the company s AGM. The remuneration payable to SPG & Associates will be higher than that paid to the outgoing auditors. The company seeks shareholder approval to authorise the Managing Director, CFO, or Company Secretary to determine the remuneration payable for each financial year. As the company has not disclosed the proposed remuneration to SPG & Associates, which is a regulatory requirement. We do not support the resolution. Hence, we are voting against.

  10 for6 against
• Ratification of remuneration of the Cost Auditors for the financial year 2025-26.

  16 for0 against
• Appointment of Mr. Anil Kumar Arvindlal Amin (DIN:10594012) as an Independent Director of the Company for five years

  17 for0 against

• Fine or penaltyJoint Commissioner of State Tax (Appeals), Kalyan - GSTSince 10 Aug 2026

  Demand Notice was issued to Akumentis Healthcare Limited, a subisidary of the Company for a demand of Rs.8,69,772/- including Tax amount of Rs.4,27,197, Interest amount of Rs.3,99,856 and Penalty amount of Rs.42,719/-

  Demand Notice was received due to mismatch in the amount of GSTR-1 and GSTR-3B and RCM liability arising from the difference between the RCM ITC availed and the corresponding amount reflected in GSTR-2B. Matter is related to Financial Year 2021-22MoreLess
• Fine or penaltyState of Himachal Pradesh through Food Safety Officer, MandiSince 30 Sep 2026

  Fine of Rs.50,000/- was imposed on Maxcure Nutravedics Limited, wholly-owned subsidiary of the Company, for the violation of Section 26(2)(ii) & 3(1)(zx) of The Food Safety and Standards Act, 2006

  Manufacturing & sale of sub-standard quality of Lycogard capsule (Lycopene, Multivitamins and Minerals Capsule) which was manufactured by Maxcure Nutravedics Limited for Cipla Limited
• Tax disputeAssessing Officer (NFAC)Since 26 Sep 2021
  Next date fixed for hearing is 26-11-2026
  At the filing before: For the assessment year 2017-18, the Deputy Commissioner of Income Tax, Chandigarh (DCIT) passed an order under section 144 of the Income Tax Act, 1961 (Act) dated September 26, 2021 (Assessment Order) whereby the income of Akums Lifesciences Ltd. (now merged with Pure & Cure Healthcare Pvt Ltd) was assessed to be Rs. 617.76 million. The DCIT also issued a notice of demand (Demand Notice) under section 156 of the Act for tax liabilities amounting to Rs. 734.46 million. Along with the Assessment Order and the Demand Notice, the DCIT issued a notice for initiation of penalty (Penalty Notice) under section 274 read with section 270A of the Act. ALL filed a civil writ petition dated November 15, 2021 (Writ Petition) before the High Court of Punjab and Haryana (P&H HC) for quashing and grant of stay against the Assessment Order, Demand Notice and the Penalty Notice. Vide order dated March 25, 2022, the P&H HC directed that the demand raised pursuant to the Assessment Order be not acted upon. The matter is currently pending.MoreLess
• Tax disputeDeputy Commissioner of Income Tax, Central DelhiSince 20 May 2026
  CIT Appeal Filed
  At the filing before: Akums Drugs and Pharmaceuticals Limited has received an assessment order dated May 20, 2026 from Income Tax Department, Office of the Deputy Commissioner of Income Tax, Central Circle 1, New Delhi under section 158BC of the Income Tax Act for the block period starting from 01.04.2018 to 12.03.2025 for a demand of Rs.60,09,22,342/- on account of disallowance of various expenditures under Section 37(1) of the Income Tax Act, 1961. Appeal was filed against the order to Commissioner of Income Tax AppealMoreLess
• Tax disputeDeputy Commissioner of Income Tax, Central DelhiSince 20 May 2026
  CIT Appeal Filed
  At the filing before: Maxcure Nutravedics Limited, wholly owned subsidiary of the Company has received an assessment order dated May 20, 2026 from Income Tax Department, Office of the Deputy Commissioner of Income Tax, Central Circle 1, New Delhi under section 158BC of the Income Tax Act for the block period starting from 01.04.2018 to 12.03.2025 for a demand of Rs. 15,23,84,730/- on account of disallowance of various expenditures under Section 37(1) of the Income Tax Act, 1961. Appeal was filed against the order to Commissioner of Income Tax AppealMoreLess
• Tax disputeDeputy Commissioner of Income Tax, Central DelhiSince 19 May 2026
  CIT Appeal Filed
  At the filing before: Akumentis Healthcare Limited, subsidiary of the Company has received an assessment order dated May 19, 2026 from Income Tax Department, Office of the Deputy Commissioner of Income Tax, Central Circle 1, New Delhi under section 158BC of the Income Tax Act for the block period starting from 01.04.2018 to 12.03.2025 for a demand of Rs. 73,66,10,238/- on account of disallowance of various expenditures under Section 37(1) of the Income Tax Act, 1961. Appeal was filed against the order to Commissioner of Income Tax AppealMoreLess

In the company's own words, from its latest governance filing.

The board is made up as the listing rules require

Yes

The board has a regular chairperson

No

The company has a risk management committee

Yes

The chair is related to the managing director

Yes

The filing has a part on fines and penalties

Yes

The filing has a part on tax disputes

Yes

There was a cyber security incident in the quarter

No

The company's own answers in its filing.